Skip to main content
Premium Trial:

Request an Annual Quote

Bioline MyTaq Plant-PCR Kit

Bioline, a subsidiary of Meridian Bioscience, has launched MyTaq Plant-PCR kit. The product uses a novel buffer system that is highly tolerant to PCR inhibitors typically present in plant samples and circumvents the need for traditional, time-consuming extraction steps or additional PCR stabilizers. The kit comes in a single tube with pre-optimized protocol that is easy to automate, making it ideal for high-throughput applications such as genotyping and transgenic screening, the company said.

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.